- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03608098
Long Pulse Versus Short Pulse Laser Dusting for Renal Stones
May 30, 2019 updated by: Wake Forest University Health Sciences
The purpose of this research study is to compare how well two treatments work for removing kidney stones.
The two study groups include ureteroscopy with long/short pulse lithotripsy to remove kidney stones.
Both of these options are considered standard of care and are used currently in surgery.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
This study will compare two types of laser lithotripsy to see the pulse duration to determine which settings are more effective.
This is a randomized control trial with subjects randomized to either long pulse or a short pulse group.
Those subjects with a single kidney/ureter stone measuring up to 20 mm will be eligible for the study.
The procedures will be performed using the standard of care instruments and techniques but the pulse type setting in surgery will be constant.
Some Holmium laser devices provide the option to modulate the pulse duration.
A longer laser pulse duration (700 μs or 1500 μs) as compared to a traditional pulse duration (300 μs or 350 μs) has been demonstrated in vitro studies to provide effective stone disintegration while reducing laser fiber tip degradation and stone retropulsion.
Both the long and the short setting can dust the stone and currently we alternate in each procedure from one setting to the other and it is unclear which setting is more effective.
No changes to operative technique will be performed for subjects in the study vs regular patients undergoing the same procedure.
All subjects will be seen one week to one month after surgery for stent removal and follow up.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest University Health Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Kidney/ureter single stone between up to 2 cm
- Age over 18 years
- Two kidneys
Exclusion Criteria:
- Solitary Kidney
- Age under 18
- Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Short Pulse Duration Group
A short pulse duration (300 μs or 350 μs) will be used in this group.
|
The holmium laser device will be used on a short laser pulse duration setting (300 μs or 350 μs)
|
ACTIVE_COMPARATOR: Long Pulse Duration Group
A long laser pulse duration (700 μs or 1500 μs) will be used in this group.
|
The holmuim laser device will be used on a long laser pulse duration setting (700 μs or 1500 μs)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stone free rate
Time Frame: 1 month after surgery
|
Proportion of participants free of stones after procedure reported by group
|
1 month after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Operative duration time
Time Frame: 1 month after surgery
|
Operative duration time measured by minutes
|
1 month after surgery
|
Need for Secondary Procedures
Time Frame: 1 month after surgery
|
The number of participants needing additional secondary procedures will be reported per group
|
1 month after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Jorge Gutierrez-Aceves, MD, Wake Forest University Health Sciences
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Nelson CP, Pace KT, Pais VM, Pearle MS, Preminger GM. American Urological Association (AUA) guideline surgical management of stones: American Urological Association Surgical Management 2016; April:1-50.
- Chew BH, Brotherhood HL, Sur RL, Wang AQ, Knudsen BE, Yong C, Marien T, Miller NL, Krambeck AE, Charchenko C, Humphreys MR. Natural History, Complications and Re-Intervention Rates of Asymptomatic Residual Stone Fragments after Ureteroscopy: a Report from the EDGE Research Consortium. J Urol. 2016 Apr;195(4 Pt 1):982-6. doi: 10.1016/j.juro.2015.11.009. Epub 2015 Nov 14.
- Matlaga BR, Chew B, Eisner B, Humphreys M, Knudsen B, Krambeck A, Lange D, Lipkin M, Miller NL, Monga M, Pais V, Sur RL, Shah O. Ureteroscopic Laser Lithotripsy: A Review of Dusting vs Fragmentation with Extraction. J Endourol. 2018 Jan;32(1):1-6. doi: 10.1089/end.2017.0641. Epub 2017 Nov 27.
- Li R, Ruckle D, Keheila M, Maldonado J, Lightfoot M, Alsyouf M, Yeo A, Abourbih SR, Olgin G, Arenas JL, Baldwin DD. High-Frequency Dusting Versus Conventional Holmium Laser Lithotripsy for Intrarenal and Ureteral Calculi. J Endourol. 2017 Mar;31(3):272-277. doi: 10.1089/end.2016.0547. Epub 2017 Jan 16.
- Wollin DA, Ackerman A, Yang C, Chen T, Simmons WN, Preminger GM, Lipkin ME. Variable Pulse Duration From a New Holmium:YAG Laser: The Effect on Stone Comminution, Fiber Tip Degradation, and Retropulsion in a Dusting Model. Urology. 2017 May;103:47-51. doi: 10.1016/j.urology.2017.01.007. Epub 2017 Jan 16.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
May 1, 2019
Primary Completion (ANTICIPATED)
December 1, 2022
Study Completion (ANTICIPATED)
December 1, 2023
Study Registration Dates
First Submitted
July 24, 2018
First Submitted That Met QC Criteria
July 24, 2018
First Posted (ACTUAL)
July 31, 2018
Study Record Updates
Last Update Posted (ACTUAL)
June 3, 2019
Last Update Submitted That Met QC Criteria
May 30, 2019
Last Verified
December 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Kidney Diseases
- Urologic Diseases
- Pathological Conditions, Anatomical
- Urolithiasis
- Urinary Calculi
- Calculi
- Kidney Calculi
- Nephrolithiasis
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Autonomic Agents
- Peripheral Nervous System Agents
- Adrenergic alpha-Agonists
- Adrenergic Agonists
- Respiratory System Agents
- Sympathomimetics
- Vasoconstrictor Agents
- Nasal Decongestants
- Oxymetazoline
Other Study ID Numbers
- IRB00049526
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Stone
-
Washington University School of MedicineRecruiting
-
Société Internationale d'UrologieCompletedStone Ureter | Stone, Kidney | Stone;RenalUnited States, China, Korea, Republic of, Malaysia, Saudi Arabia, Greece, India, Indonesia, Iran, Islamic Republic of, Iraq, Kenya, Romania, South Africa, Taiwan, Turkey
-
Advance Shockwave Technology GmbHUnknownKidney StonesUnited States
-
Mansoura UniversityCompletedUrologic Diseases | Stone, Kidney | Stone, Urinary | ESWL | Radiolucent Calculus of Urinary Tract | DissolutionEgypt
-
University of British ColumbiaActive, not recruiting
-
Mansoura UniversityUnknownUrologic Diseases | Stones, Kidney | Stone, Urinary | Shock Wave LithotripsyEgypt
-
Selçuk UniversityThe Scientific and Technological Research Council of TurkeySuspendedKidney StonesTurkey
-
Mansoura UniversityCompleted
-
Alnylam PharmaceuticalsTerminatedRecurrent Calcium Oxalate Kidney Stone Disease | Elevated Urinary Oxalate LevelsUnited States, Italy, Spain, Belgium, Switzerland, United Kingdom
-
VA New York Harbor Healthcare SystemCompletedKidney StonesUnited States
Clinical Trials on Short Pulse Duration
-
Deutsches Herzzentrum MuenchenCompletedParoxysmal Atrial FibrillationGermany
-
Helsinki University Central HospitalRecruitingBleeding | Cholangitis | Pancreatitis, AcuteFinland
-
University of CalgaryCompleted
-
Jose Luis Ibañez CriadoRecruitingTypical Atrial Flutter | Catheter AblationSpain
-
Cutera Inc.WithdrawnLaser Tattoo RemovalCanada
-
The Second Affiliated Hospital of Chongqing Medical...CompletedAtrial FibrillationChina
-
Lady Hardinge Medical CollegeRecruitingAntibiotic Stewardship | Early-Onset Neonatal SepsisIndia
-
AZ Sint-Jan AVCompletedAtrial FibrillationSwitzerland, Austria, Belgium, Netherlands
-
St. Louis UniversityNot yet recruiting
-
Parc de Salut MarCompleted